Hong Kong Doctors May Open Private Clinics In Guangdong
This article was originally published in PharmAsia News
Executive Summary
According to the recent Supplement V to the Hong Kong-Mainland Closer Economic Partnership Arrangement, Guangdong will be the testing ground for a series of pilot plans by year end. In healthcare, Hong Kong permanent residents of Chinese nationality - who have been practicing in the territory of Macau for at least five years - may open clinics as sole investors upon receiving the mainland's certificate of licensed practicing physician. There is no investment limit for setting up a clinic, compared to the previous regulation restricting maximum Hong Kong funding to 70 percent of the total investment. Guangdong officials believe the pilot will provide valuable reference and experience for further boosting the development of the healthcare reform. (Click here for more - Chinese Language)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.